A growing body of evidence is shifting expert opinion toward supporting MS treatment during pregnancy, emphasizing ...

Trastuzumab deruxtecan plus pertuzumab outperformed standard-of-care therapy as first-line treatment for HER2-positive ...

In addition, mirvetuximab soravtansine (Elahere) was the first targeted therapy to demonstrate an improvement in OS in ...

CHICAGO -- The bispecific T-cell engager tarlatamab (Imdelltra) significantly prolonged survival in the second-line treatment ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today positive results from the Phase III ...

As a mom to a child withhemophilia, stepping away from sports seemed to be the only way to keep him protected from a life-threatening bleed.

Genentech’s short film draws on the experiences of multiple families caring for children with hemophilia A, seeking to ...

The benefits of 52-week biologic therapy on asthma control and lung function are observed in both never smokers and ...

Genentech has announced plans to build a new biotechnology manufacturing plant in Holly Springs, North Carolina. The company, ...

Dietmar Berger, M.D., Ph.D., joined Gilead Sciences as chief medical of | Dietmar Berger became Gilead Sciences’ new chief ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive final results from the overall ...